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ntibiotic susceptibility proﬁles of clinical isolates of Acineto-
acter species isolated from Selayang hospital, Malaysia
.N.H. Maziz ∗, J. Hussaini, M.F.K. Khan
Universiti Teknologi MARA, Shah Alam, Selangor, Malaysia
Background: Acinetobacter species are important pathogen
ausing severe and life threatening infections. They emerge as
igniﬁcant nosocomial pathogens in the hospital setting and are
esponsible for intermittent outbreaks. Acinetobacter species cause
nfections that are difﬁcult to control due to multi-drug resistance.
cinetobacter species are noted for their intrinsic resistance to
ntibiotics and for their ability to acquire genes encoding resistance
eterminants. Comparative analyses of the emergenceof resistance
ssociated with different classes of drugs are lacking.
Methods: Forty clinical isolates of Acinetobacter strains were
ollected fromSelayanghospital, Selangor,Malaysiaduring January
o June 2010. All the clinically isolated samples were identiﬁed as
cinetobacter spp by the conventional biochemical tests i.e., gram
taining, catalase test, oxidase test, motility test, Triple Sugar Iron
ssay, citrate test, urease test and indole test etc. The Kirby-Bauer
isk diffusion method was used to determine the antibiotic sus-
eptibility. Results of disk diffusion method were interpreted in
ccordance to the Clinical and Laboratory Standards Institute (CLSI,
009).
Results: Thirty nine percent of the isolates were identiﬁed from
espiratory tract followed by urine (19%) and pus (18%). Aminogly-
osides (gentamicin) was found to be the most active antimicrobial
gentwith 47.5% susceptibility followedby amikacin (45%) and30%
o the beta-lactams (imipenem, ceftazidime). Meropenem showed
he maximum resistance (92.5%) followed by piperacillin (77.5%)
nd ampicillin (75%). It was also found that 5% of the Acinetobacter
trains were resistant to one antibiotic, 10% strains were resistant
o two antibiotics and 85% strains were multidrug resistant. Acine-
obacter spp. isolated from respiratory tract, urine and pus showed
he highest rate of multidrug resistance.
Conclusion:Gentamicinwas found tobe themost activeantimi-
robial agent followed by amikacin. Meropenem, piperacillin and
mpicillin cannot be used for the treatment of Acinetobacter spp
nfections as they showed the maximum resistance. Eighty ﬁve
ercentof the Acinetobacter species isolates were multidrug resis-
ant. Highest rate of multidrug resistance was found among the
cinetobacter species isolated from respiratory tract.
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The distribution of blaSHV, blaTEMand blaCTX-Mgenes inKleb-
siella pneumoniae and Escherichiae coli clinical isolates at a
tertiary hospital in South Africa
N. Mbelle1,∗, M. Mogoloane2, R. Mthombeni2, M. Le Roux2, B. De
Villiers2, L. Fernandes2
1 National health laboratory Services, Johannesburg, South Africa
2 University of Limpopo, Pretoria, South Africa
Background:Klebsiella pneumoniaeandEscherichia coliare com-
mon uropathogens. Of signiﬁcance is that resistance has developed
rapidly and spread globally, impacting negatively on patient sur-
vival andhospital resources. Sincebeta-lactamaseproduction is the
most commoncause of decreased susceptibility in these organisms,
it is important to establish the prevalence and identity of common
beta-lactamase genes. There is limited data from both South Africa
and Africa of the prevalence of blaSHV blaTEM blaCTX-M in these
important pathogens. The purpose of this study was to phenotypi-
cally characteriseKlebsiella pneumoniae and Escherichia coli isolates
at this institution and establish the distribution of blaSHV, blaTEM
and blaCTX-M.
Methods: Thirty four Klebsiella pneumoniae and forty one
Escherichia coli urinary isolates were collected over a four month
period atDrGeorgeMukhari hospital, a peri-urban tertiary hospital
in South Africa. They were identiﬁed and susceptibility established
byMicroscan®. CLSI guidelineswere used in the interpretation.The
genes were identiﬁed by PCR using blaTEM blaSHV and blaCTX-M
primers.
Results: Cotrimoxazole susceptibility was 36% and 12% for
Klebsiella pneumoniae and Escherichia coli respectively. ESBL pro-
duction was detected in 26% and 2% of Klebsiella pneumoniae and
Escherichia coli isolates respectively. Carbapenem resistance was
only detected in Klebsiella pneumonia. 3% of these isolates were
resistant to meropenem.Several specimens had multiple beta-
lactamases by molecular characterization. blaTEM was the most
commonlydetectedbeta lactamasegroup inboth species. Although
no blaSHVwas isolated in Escherichia coli, 88%of theKlebsiella pneu-
monia isolates had this gene. The blaCTX-M gene was found in 53%
and 3% of Klebsiella pneumoniae and Escherichia coli isolates respec-
tively. All extended spectrum beta lactamase producing isolates
contained the blaCTX-M gene.
Conclusion: This epidemiological study conﬁrms the worlwide
presence of antimicrobial resistance. Furthermore, the presence
and global spread of blaCTX-M at this institution suggests spread of
this clone to South Africa as has been reported for other countries.
This data can be used to guide antimicrobial treatment guidelines
as well as enhance infection control processes.
http://dx.doi.org/10.1016/j.ijid.2012.05.590
